Thompson, P., Campbell, M., & McNeice, A. (2023). 44 A review of glycoprotein IIB/IIIA inhibitors in primary PCI within the belfast HSC trust. Heart (British Cardiac Society), 109(Suppl 6), A50-A51. https://doi.org/10.1136/heartjnl-2023-ICS.44
Chicago Style (17th ed.) CitationThompson, P., M. Campbell, and A. McNeice. "44 A Review of Glycoprotein IIB/IIIA Inhibitors in Primary PCI Within the Belfast HSC Trust." Heart (British Cardiac Society) 109, no. Suppl 6 (2023): A50-A51. https://doi.org/10.1136/heartjnl-2023-ICS.44.
MLA (9th ed.) CitationThompson, P., et al. "44 A Review of Glycoprotein IIB/IIIA Inhibitors in Primary PCI Within the Belfast HSC Trust." Heart (British Cardiac Society), vol. 109, no. Suppl 6, 2023, pp. A50-A51, https://doi.org/10.1136/heartjnl-2023-ICS.44.